Galectin Therapeutics (GALT) - Shares outstanding

Number of shares outstanding as of December 2025 : 64,205,000

According to Galectin Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 64,205,000. At the end of 2025 the company had 64,205,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Galectin Therapeutics from 2012 to 2025

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2025	64.2 M	3.09%
2024	62.27 M	4.31%
2023	59.7 M	0.52%
2022	59.39 M	0.18%
2021	59.29 M	3.93%
2020	57.04 M	0.73%
2019	56.63 M	38.39%
2018	40.92 M	16.37%
2017	35.16 M	20.09%
2016	29.28 M	23.07%
2015	23.79 M	7.9%
2014	22.05 M	29.8%
2013	16.98 M	7.37%
2012	15.82 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Mirati Therapeutics MRTX	64,993,079	1.23%	🇺🇸 USA
MannKind Corp MNKD	306,806,000	377.85%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for Galectin Therapeutics (GALT)

Number of shares outstanding as of December 2025 : 64,205,000